Sodium borohydride → 3-[(4-Chlorophenyl)methyl]-2-(1-methylethyl)-3,4,5,6,7,8-hexahydrocyclohepta[d]imidazol-4-ol
反応式
[BH4-].[Na+].[Cl:3][C:4]1[CH:9]=[CH:8][C:7]([CH2:10][N:11]2[C:15]3[C:16](=[O:21])[CH2:17][CH2:18][CH2:19][CH2:20][C:14]=3[N:13]=[C:12]2[CH:22]([CH3:24])[CH3:23])=[CH:6][CH:5]=1>ClCCl.CO>[Cl:3][C:4]1[CH:5]=[CH:6][C:7]([CH2:10][N:11]2[C:15]3[CH:16]([OH:21])[CH2:17][CH2:18][CH2:19][CH2:20][C:14]=3[N:13]=[C:12]2[CH:22]([CH3:24])[CH3:23])=[CH:8][CH:9]=1参加物
5
反応物 2
生成物 1
試薬・触媒・溶媒 2
実験手順
Sodium borohydride (100 mg) was added to a stirred solution of Intermediate 3 (420 mg) in dichloromethane (3 ml) and methanol (3.00 ml). The reaction mixture was stirred for 1 hour. The reaction mixture was partitioned between EtOAc (50 ml) and water (30 ml). The two phases were separated and the aqueous phase was extracted again with EtOAc (30 ml). The phases were separated, the organic extracts were combined, dried (hydrophobic frit) and concentrated under vacuum to give the title compound (376 mg). LC/MS MH+ 319, Rt 0.77 min (2 minute run).
後処理
- customThe reaction mixture was partitioned between EtOAc (50 ml) and water (30 ml)
- customThe two phases were separated
- extractionthe aqueous phase was extracted again with EtOAc (30 ml)
- customThe phases were separated
- customdried (hydrophobic frit)
- concentrationconcentrated under vacuum
出典と根拠
- ORDレコード
- ord-9e4f903e09dd4b358eb9df5806a75c35
- 出典データセット
- uspto-grants-2013_03
- 特許番号
- US08399444B2
反応ノート
読み込み中…